Cargando…

Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?

BACKGROUND: Multiple system atrophy (MSA) is a rare neurodegenerative disorder, and its parkinsonian variant can be difficult to delineate from Parkinson's disease (PD). Despite laryngeal dysfunction being associated with decreased life expectancy and quality of life, systematic assessments of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gandor, Florin, Vogel, Annemarie, Claus, Inga, Ahring, Sigrid, Gruber, Doreen, Heinze, Hans‐Jochen, Dziewas, Rainer, Ebersbach, Georg, Warnecke, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818263/
https://www.ncbi.nlm.nih.gov/pubmed/32757231
http://dx.doi.org/10.1002/mds.28220
_version_ 1783638799295709184
author Gandor, Florin
Vogel, Annemarie
Claus, Inga
Ahring, Sigrid
Gruber, Doreen
Heinze, Hans‐Jochen
Dziewas, Rainer
Ebersbach, Georg
Warnecke, Tobias
author_facet Gandor, Florin
Vogel, Annemarie
Claus, Inga
Ahring, Sigrid
Gruber, Doreen
Heinze, Hans‐Jochen
Dziewas, Rainer
Ebersbach, Georg
Warnecke, Tobias
author_sort Gandor, Florin
collection PubMed
description BACKGROUND: Multiple system atrophy (MSA) is a rare neurodegenerative disorder, and its parkinsonian variant can be difficult to delineate from Parkinson's disease (PD). Despite laryngeal dysfunction being associated with decreased life expectancy and quality of life, systematic assessments of laryngeal dysfunction in large cohorts are missing. OBJECTIVES: The objective of this study was to systematically assess laryngeal dysfunction in MSA and PD and identify laryngeal symptoms that allow for differentiating MSA from PD. METHODS: Patients with probable or possible MSA underwent flexible endoscopic evaluation of swallowing performing a systematic task protocol. Findings were compared with an age‐matched PD cohort. RESULTS: A total of 57 patients with MSA (64 [59–71] years; 35 women) were included, and task assessments during endoscopic examination compared with 57 patients with PD (67 [60–73]; 28 women). Patients with MSA had a shorter disease duration (4 [3–5] years vs 7 [5–10]; P < 0.0001) and higher disease severity (Hoehn & Yahr stage 4 [3–4] vs 3 [2–4]; P < 0.0001). Of the patients with MSA, 43.9% showed clinically overt laryngeal dysfunction with inspiratory stridor. During endoscopic task assessment, however, 93% of patients with MSA demonstrated laryngeal dysfunction in contrast with only 1.8% of patients with PD (P < 0.0001). Irregular arytenoid cartilages movements were present in 91.2% of patients with MSA, but in no patients with PD (P < 0.0001). Further findings included vocal fold motion impairment (75.4%), paradoxical vocal fold motion (33.3%), and vocal fold fixation (19.3%). One patient with PD showed vocal fold motion impairment. CONCLUSION: Laryngeal movement disorders are highly prevalent in patients with MSA when assessed by a specific task protocol despite the lack of overt clinical symptoms. Our data suggest that irregular arytenoid cartilage movements could be used as a clinical marker to delineate MSA from PD with a specificity of 1.0 and sensitivity 0.9. © 2020 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society
format Online
Article
Text
id pubmed-7818263
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-78182632021-01-29 Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker? Gandor, Florin Vogel, Annemarie Claus, Inga Ahring, Sigrid Gruber, Doreen Heinze, Hans‐Jochen Dziewas, Rainer Ebersbach, Georg Warnecke, Tobias Mov Disord Regular Issue Articles BACKGROUND: Multiple system atrophy (MSA) is a rare neurodegenerative disorder, and its parkinsonian variant can be difficult to delineate from Parkinson's disease (PD). Despite laryngeal dysfunction being associated with decreased life expectancy and quality of life, systematic assessments of laryngeal dysfunction in large cohorts are missing. OBJECTIVES: The objective of this study was to systematically assess laryngeal dysfunction in MSA and PD and identify laryngeal symptoms that allow for differentiating MSA from PD. METHODS: Patients with probable or possible MSA underwent flexible endoscopic evaluation of swallowing performing a systematic task protocol. Findings were compared with an age‐matched PD cohort. RESULTS: A total of 57 patients with MSA (64 [59–71] years; 35 women) were included, and task assessments during endoscopic examination compared with 57 patients with PD (67 [60–73]; 28 women). Patients with MSA had a shorter disease duration (4 [3–5] years vs 7 [5–10]; P < 0.0001) and higher disease severity (Hoehn & Yahr stage 4 [3–4] vs 3 [2–4]; P < 0.0001). Of the patients with MSA, 43.9% showed clinically overt laryngeal dysfunction with inspiratory stridor. During endoscopic task assessment, however, 93% of patients with MSA demonstrated laryngeal dysfunction in contrast with only 1.8% of patients with PD (P < 0.0001). Irregular arytenoid cartilages movements were present in 91.2% of patients with MSA, but in no patients with PD (P < 0.0001). Further findings included vocal fold motion impairment (75.4%), paradoxical vocal fold motion (33.3%), and vocal fold fixation (19.3%). One patient with PD showed vocal fold motion impairment. CONCLUSION: Laryngeal movement disorders are highly prevalent in patients with MSA when assessed by a specific task protocol despite the lack of overt clinical symptoms. Our data suggest that irregular arytenoid cartilage movements could be used as a clinical marker to delineate MSA from PD with a specificity of 1.0 and sensitivity 0.9. © 2020 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society John Wiley & Sons, Inc. 2020-08-05 2020-12 /pmc/articles/PMC7818263/ /pubmed/32757231 http://dx.doi.org/10.1002/mds.28220 Text en © 2020 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Regular Issue Articles
Gandor, Florin
Vogel, Annemarie
Claus, Inga
Ahring, Sigrid
Gruber, Doreen
Heinze, Hans‐Jochen
Dziewas, Rainer
Ebersbach, Georg
Warnecke, Tobias
Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?
title Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?
title_full Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?
title_fullStr Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?
title_full_unstemmed Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?
title_short Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?
title_sort laryngeal movement disorders in multiple system atrophy: a diagnostic biomarker?
topic Regular Issue Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818263/
https://www.ncbi.nlm.nih.gov/pubmed/32757231
http://dx.doi.org/10.1002/mds.28220
work_keys_str_mv AT gandorflorin laryngealmovementdisordersinmultiplesystematrophyadiagnosticbiomarker
AT vogelannemarie laryngealmovementdisordersinmultiplesystematrophyadiagnosticbiomarker
AT clausinga laryngealmovementdisordersinmultiplesystematrophyadiagnosticbiomarker
AT ahringsigrid laryngealmovementdisordersinmultiplesystematrophyadiagnosticbiomarker
AT gruberdoreen laryngealmovementdisordersinmultiplesystematrophyadiagnosticbiomarker
AT heinzehansjochen laryngealmovementdisordersinmultiplesystematrophyadiagnosticbiomarker
AT dziewasrainer laryngealmovementdisordersinmultiplesystematrophyadiagnosticbiomarker
AT ebersbachgeorg laryngealmovementdisordersinmultiplesystematrophyadiagnosticbiomarker
AT warnecketobias laryngealmovementdisordersinmultiplesystematrophyadiagnosticbiomarker